RPS | Jotup

MC Squared Energy Services (MC2) Celebrates Earth Day 2024 With Annual Green Initiative

Retrieved on:

수요일, 4월 17, 2024

MC2, Electricity, Guarantee of origin, Wind, Environment, REC, Earth Day, Energy, CO2, RPS, Renewable energy

To celebrate Earth Day 2024, on Monday, April 22, MC2 will retire Midwest-generated Renewable Energy Certificates (RECs) equal to 100% of the energy its customers consume this day.

Key Points:

To celebrate Earth Day 2024, on Monday, April 22, MC2 will retire Midwest-generated Renewable Energy Certificates (RECs) equal to 100% of the energy its customers consume this day.
CHICAGO, April 17, 2024 (GLOBE NEWSWIRE) -- MC Squared Energy Services, LLC (MC2), a Chicago based retail electric supplier, will celebrate Earth Day 2024 with their annual green initiative.
On Earth Day 2024, MC2 is projected to retire wind and solar generated renewable energy certificates equivalent to eliminating more than 2,500 metric tons of CO2 from the atmosphere.
Striving to build a sustainable future, MC Squared Energy Services proudly offers its EcoGreen Power Supply Program and Community Solar Savings Program as easy opportunities for its customers to support renewable energy generation resources.

Identity & Access Forum Launches Industry’s First Template for Building Mobile Driver’s License Use Cases

Retrieved on:

수요일, 4월 17, 2024

Ecosystem, String interpolation, Law enforcement, Government, Organization, MDL, Privacy, IDS, Access, RPS, ID, Identity, Internet access, Risk management

In the U.S., the secure, cryptographically protected, digital identity credential is available in six states, representing more than 66 million people.

Key Points:

In the U.S., the secure, cryptographically protected, digital identity credential is available in six states, representing more than 66 million people.
In response, the Secure Technology Alliance’s Identity and Access Forum has launched the industry’s first mDL use case template.
To that end, the Secure Technology Alliance and its Identity and Access Forum have been instrumental in driving forward the implementation of mDLs,” said Sandy Mayfield, managing director of the Identity and Access Forum.
The template was created by the Identity and Access Forum’s Jumpstart Committee, a subcommittee of the Digital Identity Working Committee.

EQS-News: SIBUR attends Geneva roundtable, discusses projects to reduce plastic pollution

Retrieved on:

수요일, 4월 10, 2024

Carbon, RPS, Environment, Recycling, Polymer, United Nations, Food, RPET, Ecumene, News, Chemistry, CO2, RPO, Collection, Sustainable development, Football

Under its Vivilen brand, SIBUR produces a range of polymers containing recycled plastic for various applications: food (rPET), non-food (rPO) and home decor (rPS).

Key Points:

Under its Vivilen brand, SIBUR produces a range of polymers containing recycled plastic for various applications: food (rPET), non-food (rPO) and home decor (rPS).
SIBUR is implementing a number of plastic collection and recycling projects in collaboration with various partners in its regions of operations.
According to the Russian Carbon Unit Registry, SIBUR has one of the largest portfolios of climate projects among the Russian companies.
SIBUR’s climate projects are set to reduce CO2 emissions by over 6 million tons by the end of 2032.

Agendia Announces New Data from I-SPY 2 Showcasing Ability of New Signature ImPrintTN to Predict Immunotherapy Response in Patients with Triple Negative Breast Cancer

Retrieved on:

수요일, 3월 20, 2024

Agendia®, Inc. today announced new data from the I-SPY 2 trial showcasing its ImPrint signature for patients with triple negative (TN) breast cancer, shared by I-SPY 2 researchers in an oral presentation at the 14th European Breast Cancer Conference in Milan, Italy.

Key Points:

Agendia®, Inc. today announced new data from the I-SPY 2 trial showcasing its ImPrint signature for patients with triple negative (TN) breast cancer, shared by I-SPY 2 researchers in an oral presentation at the 14th European Breast Cancer Conference in Milan, Italy.
Agendia has been in partnership with Quantum Leap Healthcare Collaborative, the sponsors of the neoadjuvant biomarker-rich I-SPY 2 trial, since 2010.
), investigates the utility of a refined version of ImPrint, called ImPrintTN, designed to provide more accurate predictions to response to common immunotherapy (IO) regimens for TN patients.
“Many immunotherapy treatments can have difficult, severe adverse side effects on patients that can outweigh the benefit of the treatment.

Greenhouse Gas Emissions Are Dropping in Key Sectors, but California Still Not on Pace to Achieve 2030 Climate Goal as Emissions Rebound Following Lockdown

Retrieved on:

목요일, 3월 14, 2024

If you look at the trajectory since 2010, California won’t meet our 2030 climate goal until 2047.

Key Points:

If you look at the trajectory since 2010, California won’t meet our 2030 climate goal until 2047.
But overall, greenhouse gas emissions from passenger cars, heavy-duty trucks, and other vehicles were more than 10% lower in 2021 compared to 2019.
California’s cement plants account for two percent of total statewide carbon emissions and almost 10 percent of industrial emissions.
Despite light-duty vehicles emissions increasing 10.6% (+10.0 MMTCO2e) from 2020 to 2021, overall transportation emissions are trending downward in California.

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

Retrieved on:

수요일, 2월 28, 2024

“The data presented at ECR demonstrate the real-world ability to improve efficiency and accuracy in mammography breast screening—from reducing workloads without compromising accuracy to potentially reducing interval cancer rates and expediting diagnosis for true positive cases.

Key Points:

“The data presented at ECR demonstrate the real-world ability to improve efficiency and accuracy in mammography breast screening—from reducing workloads without compromising accuracy to potentially reducing interval cancer rates and expediting diagnosis for true positive cases.
These findings underscore ProFound AI’s transformative power to improve breast healthcare,” said Dana Brown, president and CEO of iCAD.
Sunday, March 3, 9:30 – 11:00 am, RPS2305 – Retrospective Evaluation of Interval Breast Cancer: Can the Number of Interval Carcinomas be Reduced Utilizing AI Diagnostic Software?
Lastly, iCAD will highlight expanded cloud platform and subscription licensing plans marking a significant advancement in deployment flexibility.

Draft revised consolidated 3-year work plan for the Methodology Working Party (MWP)

Retrieved on:

수요일, 2월 14, 2024

Real-World Evidence, ACT, Data science, CMD, Toxicity, Budesonide, Paliperidone palmitate, Drug development, E20, RWE, ETF, Human, Pharmacology, Machine learning, Quantitative systems pharmacology, Register, Radiopharmaceutical, Legislation, QST, M12, CAT, Salt, Pharmacoepidemiology, Dasatinib, Algorithm, M13, Azacitidine, Methylphenidate, Clinical trial, Health, M&S, Methodology, PBPK, HMA, Adverse drug reaction, European, CHMP, HTA, Biomarker, Big data, Digoxin, Betahistine, Multi, Therapy, Medication package insert, Simulation, LALA, ADR, US FDA, Language, RWD, Corr, PBBM, WPS, SAWP, Committee, Pharmacovigilance, Peptide, ICH, CPS, Contribution, Good, QSP, Model, Epidemiology, Artificial intelligence, RPS, Research, Reproduction, PRAC, EMA, Health Canada, AI, Cross, Gastrointestinal tract, Paliperidone, Communication, Risk, Melatonin, MWP, CP, Medicine, Patient, Biostatistics, Pharmacokinetics, Oligonucleotide, E21, M14, Q&A, Drug, M15, Medical device

Industry level .................................................................................................. 13

Key Points:

Industry level .................................................................................................. 13
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023

Page 2/14

1.
A reflection paper
(RP) on the clinical pharmacology package for oligonucleotides is a prioritised activity in the MWP work
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023

Page 3/14

plan, and it is envisaged that something similar may be needed for other emerging treatment
modalities (e.g., peptides).
Guideline work led by other working parties
?
Revision of the guideline on the requirements for clinical documentation for orally inhaled
products (CPMP/EWP/4151/00 Rev.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 4/14

The planned concept papers (CPs) will formulate problem statements for potential workshops and
subsequent guidance documents will be informed and enriched by the outcome of discussions of
workshops to be held in 2024.
Guideline work led by other working parties and committees
?
Revision of Guidance on the investigation of medicinal products in the term and preterm
neonate (EMEA/536810/2008).
There is a need for
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 5/14

new guidance in these areas to ensure these novel approaches meet the required evidentiary
standards and facilitate their evaluation.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 6/14

?

Revision of Guideline on clinical evaluation of diagnostic agents (CPMP/EWP/1119/98/Rev.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 7/14

?

Provide appropriate support to the EU network for generic and hybrid medicines including
product-specific requirements.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 8/14

2.3.
?
Cross disciplinary work with Quality Working Party and other stakeholders on physiologically
based biopharmaceutics modelling (PBBM).
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 9/14

?

In order to support adequate evaluation of all methodology MWP will aim to facilitate an
increase in presence and visibility in relevant committees of methodological expertise from
across the EU network such as CHMP, PRAC, PDCO, CMD(h), ETF and CAT.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 10/14

?

Product Specific Bioequivalence Guidelines (PSBGLs) (multiple) in liaison with CMD(h): for
2024, azacitidine, budesonide (LALA GIT), trametinib, dabrafenib, paliperidone palmitate (3M
depot) and melatonin have been prioritised as the next in series for drafting.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 11/14

4.2.
?
Cross disciplinary work with Quality Working Party and other stakeholders on PBBM model
assessment.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 12/14

?

To deliver an improved access to raw data (e.g.
?
Propose regulatory research priorities for funders in across the activities of Methodology
Working Party, including in the big data area.
?
Establish key communication points in national competent authorities and build a resource of
key messages and communication materials on regulation and methodology.
The timing of workshops may need to be arranged according to the
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023

Page 13/14

specific needs of the guidance ? either before the guidance is finalised to gather views and
expertise; or once it is finalised for training purposes.
Revised consolidated 3-year work plan for the Methodology Working Party (MWP)
EMA/CHMP/58124/2023
Page 14/14

T. ROWE PRICE APPOINTS COMPANY VETERANS TO LEAD U.S. INTERMEDIARIES AND RETIREMENT PLAN SERVICES BUSINESS UNITS

Retrieved on:

수요일, 2월 7, 2024

MOSAIC, Consultant, Human resources, Society, Retirement, Marketing, Investment, Corporation, Communication, RPS, T. Rowe Price, Platform, Culture, USI

BALTIMORE, Feb. 7, 2024 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ – GS: TROW), announced today that company veterans Kevin Collins and Francisco Negrón will take on new positions leading the firm's businesses serving the U.S. intermediary and retirement services channels. The appointments are effective on March 1, 2024.

Key Points:

Intermediaries (USI), T. Rowe Price's business supporting financial advisors and consultants in the intermediary channel.
Since 2019, Collins has been the head of Retirement Plan Services (RPS), which provides investments and record keeping services for sponsors and participants of workplace retirement plans.
Collins joined T. Rowe Price in 1994 and has held positions of increasing responsibility throughout his career.
Brown and Zurad are also company veterans, having joined T. Rowe Price in 1993 and 1996, respectively.

Clean Energy Technologies Affiliate Announces Favorable Order from Maine Public Utilities Commission

Retrieved on:

수요일, 2월 7, 2024

Growth, Certification, Biomass, Environment, RPS, Biochar, HTAP, IRR, Inflation, Electricity, VRG, PUC, Renewable energy

IRVINE, CA., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (NASDAQ: CETY), a clean energy manufacturing and services company, offering eco-friendly green energy solutions, clean energy fuels, and alternative electric power for small and mid-sized projects in North America, Europe, and Asia announced today that Vermont Renewable Gas, LLC (VRG), an affiliate limited liability company, has received a favorable order from the State of Maine Public Utilities Commission (PUC).

Key Points:

IRVINE, CA., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (NASDAQ: CETY), a clean energy manufacturing and services company, offering eco-friendly green energy solutions, clean energy fuels, and alternative electric power for small and mid-sized projects in North America, Europe, and Asia announced today that Vermont Renewable Gas, LLC (VRG), an affiliate limited liability company, has received a favorable order from the State of Maine Public Utilities Commission (PUC).
The order grants New Renewable Resource Certification status for VRG – Lyndon, a 2.2 MW biogas generator facility under development in Lyndonville, Vermont.
The PUC’s decision allows VRG to participate in the trading of Renewable Energy Certificates within the state’s market.
CETY is focused on HTAP for transforming industrial, municipal, landfill, agricultural, and forestry waste into clean energy, aligning with the growing investment in clean energy solutions for commercial, industrial, and municipal sectors.

Nepal Clearing House Taps ACI Worldwide to Pioneer Card Payment Central Infrastructure

Retrieved on:

화요일, 2월 6, 2024

Once this card payment central infrastructure is established as a part of NPS-NCS, banks and financial institutions in Nepal will be able to provide domestic NEPALPAY cards to their customers which will help increase acceptance, implement data localization and reduce transaction charges.

Key Points:

Once this card payment central infrastructure is established as a part of NPS-NCS, banks and financial institutions in Nepal will be able to provide domestic NEPALPAY cards to their customers which will help increase acceptance, implement data localization and reduce transaction charges.
"The establishment of National Payment Switch (NPS) infrastructure and rollout of NEPALPAY card is expected to become a significant stride in Nepal to reform and consolidate the entire payment ecosystem.
"ACI has a stellar track record in providing scalable and innovative solutions to build transformative payment capabilities, and we are excited to bring seamless and convenient card payment services in Nepal."
ACI currently powers 25 domestic and pan-regional real-time schemes across six continents - including nine central infrastructures - providing solutions to central banks, participant banks, fintech and other payment service providers.